In order to facilitate ease of investing for investors and to secure their rights in the securities purchased by them, Securities and Exchange Board of India, vide its Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated January 30, 2026, Marksans Pharma has informed that it has extended a special window to facilitate re-lodgment of transfer deeds that were lodged with respect to shares purchased/sold prior to April 1, 2019 but were rejected, returned or not attended to due to deficiencies in transfer documents or other reasons. In connection with the above matter, it has enclosed a public notice for information of shareholders of the Company.
The above information is a part of company’s filings submitted to BSE.
